Comparison of iodine quantification and conventional attenuation measurements for differentiating small, truly enhancing renal masses from high-attenuation nonenhancing renal lesions with dual-energy CT

• Verfasst von: Meyer, Mathias [VerfasserIn]
• Verfasst von: Schönberg, Stefan [VerfasserIn]
• Titel: Comparison of iodine quantification and conventional attenuation measurements for differentiating small, truly enhancing renal masses from high-attenuation nonenhancing renal lesions with dual-energy CT
• Verf.angabe: Mathias Meyer, Rendon C. Nelson, Federica Vernuccio, Fernando Gonzalez, Christoph Schabel, Achille Mileto, Bhavik N. Patel, Stefan O. Schoenberg, Daniele Marin
• Jahr: 2019
• Umfang: 12 S.
• Fussnoten: Gesehen am 31.07.2019
• Titel Quelle: Enthalten in: American journal of roentgenology
• Ort Quelle: Leesburg, Va. : American Roentgen Ray Society, 1965
• Jahr Quelle: 2019
• Band/Heft Quelle: 213(2019,1) Seite W26-W37, 12 Seiten
• ISSN Quelle: 1546-3141
• DOI: doi:10.2214/AJR.18.20547
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: dual energy
• Sach-SW: enhancement
• Sach-SW: iodine quantification
• Sach-SW: renal lesion
• K10plus-PPN: 1670338274

Abstract

OBJECTIVE: The purpose of this study is to determine whether iodine quantification techniques from contrast-enhanced dual-energy CT (DECT) data allow equal differentiation of small enhancing renal masses from high-attenuation (> 20 HU of unenhanced attenuation) nonenhancing lesions, compared with conventional attenuation measurements. - MATERIALS AND METHODS: A total of 220 nonconsecutive patients (mean [± SD] age, 66 ± 13 years; 130 men and 90 women) with 265 high-attenuation renal lesions (mean attenuation, 54 ± 33 HU; 91 enhancing lesions) were included. Each patient underwent single-energy unenhanced CT followed by DECT during the nephrographic phase using one of four different high-end DECT platforms (first- and second-generation rapid-kilovoltage-switching DECT platforms and second- and third-generation dual-source DECT platforms). Iodine quantification measurements and conventional attenuation change measurements were calculated for each lesion. Diagnostic accuracy was determined by pathologic analysis, confirmation with another imaging modality, or greater than 24 months of imaging follow-up as the reference standard. - RESULTS: The diagnostic accuracy for differentiating enhancing from nonenhancing renal lesions was significantly higher for conventional attenuation change measurements, compared with iodine quantification measurements (AUC values, 0.973 vs 0.875; p < 0.0001). The diagnostic performance of iodine quantification measurements improved only marginally with the utilization of DECT platform-specific optimized iodine quantification thresholds, yielding AUC values of 0.907 and 0.893 for the rapid-kilovoltage-switching DECT and dual-source DECT platforms, respectively. Unenhanced lesion attenuation (p = 0.0010) and intraparenchymal location (p = 0.0249) significantly influenced the diagnostic accuracy of the iodine quantification techniques. - CONCLUSION: Iodine quantification from DECT data yields inferior diagnostic accuracy when compared with conventional attenuation change measurements for differentiating small, truly enhancing renal masses and high-attenuation renal lesions.